ClaimBack vs Olive AI: Comparing Healthcare AI Appeal Tools

Olive AI was one of the most-hyped healthcare AI companies of the early 2020s, raising over $900 million and promising to automate the most tedious parts of healthcare administration. By late 2023, Olive had shut down or sold off most of its operations — a cautionary tale about the gap between healthcare AI hype and practical reality.

But the market need Olive was trying to address hasn't gone away. Practices still need better tools for insurance appeals. The question is: what actually works?

This comparison looks at what Olive AI was, what happened to it, and how ClaimBack approaches the same problem more sustainably.

What Was Olive AI?

Olive AI launched in 2012 as a healthcare automation company. It grew rapidly through the late 2010s and early 2020s, raising hundreds of millions in venture capital and reaching a valuation of over $4 billion at its peak.

Olive's core technology was robotic process automation (RPA) — software "robots" that mimicked human actions in healthcare systems to automate tasks like Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization, eligibility verification, and claims management. Over time, it layered in machine learning and expanded into AI-driven workflows.

Olive's Healthcare AI Offerings (at peak)

• Prior authorization automation — Submitting and tracking prior auth requests
• Eligibility verification — Real-time insurance verification
• Claims management — Automating parts of the claims submission process
• Denial management — Identifying and routing denials for response

What Happened to Olive AI?

In 2023, Olive began winding down operations and selling off its product lines. The company's prior authorization business was acquired by Availity. Other business units were sold separately or shut down. The RPA-heavy approach proved difficult to maintain at scale — payer portal changes broke automations constantly, and the labor required to maintain "robots" across hundreds of payer interfaces was unsustainable.

Olive's story is a lesson: automation that mimics humans rather than replacing human reasoning tends to be brittle.

What ClaimBack Does Differently

ClaimBack doesn't try to automate payer portal navigation or mimic human actions. It focuses on one specific, high-value problem: helping providers write better appeal letters faster.

This is a fundamentally different approach. Instead of robotic process automation (which breaks when payers change their portals), ClaimBack uses natural language AI to generate the clinical and legal arguments that win appeals.

The letter still has to be submitted through the payer portal or by mail — ClaimBack doesn't try to do that for you. But the hardest part — knowing what to write, how to frame the argument, and what evidence to include — is handled by AI.

This approach is:

• More reliable — Language models don't break when payer portals update
• More valuable — The quality of the appeal argument is what drives outcomes
• More accessible — No need for enterprise-scale implementation

Comparing the Approaches

What Olive's Collapse Tells Us About Healthcare AI

Several important lessons emerge from Olive's trajectory:

1. Automation that mimics humans is fragile

RPA bots that navigate insurance portals require constant maintenance. Every time a payer changes their portal interface, the bots break. The ongoing maintenance cost of RPA-based healthcare AI is enormous and often invisible in the initial sales pitch.

2. Complexity doesn't equal value

Olive raised nearly a billion dollars and built a massive engineering organization. But the core problem — helping providers get paid faster — doesn't require that level of complexity. It requires deep knowledge of how insurance appeals work and the ability to apply that knowledge at the point of need.

3. Accessibility matters

A tool that requires a six-month implementation and a dedicated IT team serves maybe 5% of the market. The other 95% — small practices, independent physicians, specialty clinics — need something they can use today.

The Prior Authorization Connection

One of Olive's most valuable products was prior authorization automation, which was acquired by Availity. Prior auth and denial management are related but distinct problems:

• Prior authorization = getting approval before providing care
• Denial management = recovering payment after care was denied

Both matter for revenue cycle health, but denial management is more immediately actionable for most practices. You can't always change a payer's prior auth requirements, but you can almost always write a better appeal letter.

ClaimBack focuses entirely on the denial response side — which is where most practices are losing the most recoverable revenue.

Who Should Use ClaimBack in 2025

The practices that get the most value from ClaimBack share a few characteristics:

High Denial Rates by Insurer (2026)" class="auto-link">denial rates: If more than 5% of your claims are being denied, you need a systematic approach to appealing them. Manual processes don't scale.

Limited billing staff: Solo and small group practices often have one part-time billing coordinator handling everything. ClaimBack dramatically reduces the time burden of appeals.

Abandoned appeals: If your team has a habit of writing off denials under a certain dollar amount because "it's not worth the time," ClaimBack changes that calculus by making each appeal letter a 2-minute task instead of a 45-minute one.

Specialty practices: Physical therapists, mental health providers, chiropractors, home health agencies, and DME providers face above-average denial rates and benefit disproportionately from better appeals.

Pricing Reality

Olive AI charged enterprise prices for enterprise implementations. ClaimBack charges $49/month with no long-term commitment.

The Olive approach required a significant procurement process, an implementation team, ongoing maintenance contracts, and dedicated staff to manage the automation. The total cost of ownership for an Olive engagement was typically six figures per year.

ClaimBack is designed to deliver immediate ROI to any practice that can afford a cell phone bill. If you recover just one additional $50 denied claim per month, the tool pays for itself. Most practices recover far more.

Conclusion

Olive AI represented the height of healthcare AI ambition — and its collapse showed what happens when that ambition exceeds practical utility. ClaimBack takes the opposite approach: focused, accessible, immediately useful.

If you're looking for what Olive promised but couldn't deliver — practical AI that actually helps providers recover denied revenue — ClaimBack is the answer.

Start your free trial today. Sign up at ClaimBack — AI-powered appeal letters, $49/month, no long-term contract.